Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127026051 | 12702605 | 1 | I | 20160621 | 20160622 | 20160831 | 20160831 | PER | US-JNJFOC-20160704043 | JANSSEN | 50.32 | YR | A | F | Y | 120.66000 | KG | 20160831 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127026051 | 12702605 | 1 | SS | STELARA | USTEKINUMAB | 1 | Subcutaneous | N | FKS03MC;FKS03MC | 0 | 90 | MG | SOLUTION FOR INJECTION | ||||||
127026051 | 12702605 | 2 | PS | STELARA | USTEKINUMAB | 1 | Subcutaneous | N | FKS03MC;FKS03MC | 125261 | 90 | MG | SOLUTION FOR INJECTION | ||||||
127026051 | 12702605 | 3 | C | HYDROCHLOROTHIAZIDE. | HYDROCHLOROTHIAZIDE | 1 | Unknown | 0 | 50 | MG | UNSPECIFIED | ||||||||
127026051 | 12702605 | 4 | C | ATORVASTATIN | ATORVASTATIN | 1 | Unknown | 0 | 40 | MG | UNSPECIFIED | ||||||||
127026051 | 12702605 | 5 | C | FENOFIBRATE. | FENOFIBRATE | 1 | Unknown | 0 | 134 | MG | UNSPECIFIED | ||||||||
127026051 | 12702605 | 6 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Unknown | 0 | 1000 | MG | UNSPECIFIED | ||||||||
127026051 | 12702605 | 7 | C | POTASSIUM | POTASSIUM | 1 | Unknown | SUPPLEMENT | 0 | 40 | MEQ | UNSPECIFIED | |||||||
127026051 | 12702605 | 8 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Unknown | 0 | 5 | MG | UNSPECIFIED | ||||||||
127026051 | 12702605 | 9 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | Unknown | INDIGESTION | 0 | 40 | MG | UNSPECIFIED | |||||||
127026051 | 12702605 | 10 | C | MAGNESIUM | MAGNESIUM | 1 | Unknown | SUPPLEMENT | 0 | 400 | MG | UNSPECIFIED | |||||||
127026051 | 12702605 | 11 | C | DULOXETINE. | DULOXETINE | 1 | Unknown | 0 | 60 | MG | UNSPECIFIED | ||||||||
127026051 | 12702605 | 12 | C | DULOXETINE. | DULOXETINE | 1 | Unknown | 0 | 60 | MG | UNSPECIFIED | ||||||||
127026051 | 12702605 | 13 | C | LEVEMIR | INSULIN DETEMIR | 1 | Subcutaneous | 0 | 60 | MG | UNSPECIFIED | ||||||||
127026051 | 12702605 | 14 | C | VICTOZA | LIRAGLUTIDE | 1 | Unknown | 0 | 1.8 | MG | UNSPECIFIED |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127026051 | 12702605 | 1 | Psoriasis |
127026051 | 12702605 | 2 | Psoriatic arthropathy |
127026051 | 12702605 | 3 | Hypertension |
127026051 | 12702605 | 4 | Blood cholesterol increased |
127026051 | 12702605 | 5 | Blood cholesterol increased |
127026051 | 12702605 | 6 | Diabetes mellitus |
127026051 | 12702605 | 8 | Hypertension |
127026051 | 12702605 | 11 | Pain |
127026051 | 12702605 | 12 | Diabetes mellitus |
127026051 | 12702605 | 13 | Diabetes mellitus |
127026051 | 12702605 | 14 | Diabetes mellitus |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127026051 | 12702605 | Drug dose omission | |
127026051 | 12702605 | Incorrect product storage | |
127026051 | 12702605 | Syringe issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
127026051 | 12702605 | 4 | 2013 | 0 | ||
127026051 | 12702605 | 5 | 2014 | 0 | ||
127026051 | 12702605 | 6 | 2013 | 0 | ||
127026051 | 12702605 | 7 | 2014 | 0 | ||
127026051 | 12702605 | 8 | 2015 | 0 | ||
127026051 | 12702605 | 9 | 2006 | 0 | ||
127026051 | 12702605 | 10 | 2015 | 0 | ||
127026051 | 12702605 | 13 | 2013 | 0 | ||
127026051 | 12702605 | 14 | 2013 | 0 |